title: Endogenous Phialemonium curvatum endophthalmitis.
abstract: OBJECTIVE
  To report a case of bilateral endogenous Phialemonium curvatum endophthalmitis, secondary to intrapenile injections for erectile dysfunction.
  
  
  METHODS
  Observational case report.
  
  
  METHODS
  A 71-year-old man with P. curvatum endocarditis and bilateral decreased vision was diagnosed as having bilateral endogenous endophthalmitis. P. curvatum was identified in cultures that were performed on samples of the vitreous. Treatment consisted of bilateral vitrectomy and intraocular and systemic antifungals.
  
  
  RESULTS
  Despite resolution of the systemic infection, the patient's postoperative visual acuity remained limited to hand movement, and the ophthalmic clinical picture remained unchanged.
  
  
  CONCLUSIONS
  P. curvatum is a pathogen that can be readily isolated from the vitreous. The authors are unaware of previous reported cases of ocular infection that was caused by P. curvatum.
authors.affiliation: Department of Ophthalmology, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel. shirizayit@hotmail.com
authors.forename: Shiri
authors.initials: S
authors.lastname: Zayit-Soudry
authors.forename: Meira
authors.initials: M
authors.lastname: Neudorfer
authors.forename: Adiel
authors.initials: A
authors.lastname: Barak
authors.forename: Anat
authors.initials: A
authors.lastname: Loewenstein
authors.forename: Edna
authors.initials: E
authors.lastname: Bash
authors.forename: Yardena
authors.initials: Y
authors.lastname: Siegman-Igra
mesh_terms: D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use; D001203:Ascomycota / Q000302:isolation & purification*; D002387:Cataract Extraction; D004340:Drug Contamination; D004696:Endocarditis / Q000188:drug therapy / Q000382:microbiology; D009877:Endophthalmitis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology*; D007172:Erectile Dysfunction / Q000188:drug therapy; D015821:Eye Infections, Fungal / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology; D016469:Fungemia / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects; D009181:Mycoses / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology; D010276:Parasympatholytics / Q000008:administration & dosage; D011743:Pyrimidines / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use; D014463:Ultrasonography; D014821:Vitrectomy; D014822:Vitreous Body / Q000000981:diagnostic imaging / Q000382:microbiology; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D010276:Parasympatholytics; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole